1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 6,550 | 6,750 | 20:17 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | WUXI XDC Leaps 6% to Record High; WUXI BIO, WUXI APPTEC Bust Above 52-Wk Record; Citi Expects Leading CDMOs' Interim Results to Beat | 23 | AASTOCKS | ||
| 23.07. | HSI Up 283 pts; HSTI Up 98 pts; TENCENT Up over 3%; KUAISHOU-W, CHINA LIFE, NTES, HKEX, WUXI XDC Hit New Highs | 12 | AASTOCKS | ||
| 23.07. | HSI Soars 218 Pts at Open; Techs, Autos Thrive; WUXI XDC Rises 9% | 1 | AASTOCKS | ||
| 23.07. | WUXI XDC Opens 9% Higher, after Expecting Interim NP to Hike 50%+ | 2 | AASTOCKS | ||
| 23.07. | WUXI XDC Expects 50%+ YoY Growth in 1H NP | 2 | AASTOCKS | ||
| 23.07. | WUXI XDC (02268): POSITIVE PROFIT ALERT | 1 | HKEx | ||
| WUXI XDC Aktie jetzt für 0€ handeln | |||||
| 10.07. | WUXI XDC (02268): NOTICE OF BOARD MEETING | 1 | HKEx | ||
| 27.06. | WUXI XDC (02268): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | - | HKEx | ||
| 27.06. | WUXI XDC (02268): (1) POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 27, 2025; (2) CHANGE OF DIRECTORS; AND (3) CHANGE IN COMPOSITION OF BOARD ... | - | HKEx | ||
| 28.05. | WUXI XDC (02268): FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, JUNE 27, 2025 | 1 | HKEx | ||
| 28.05. | WUXI XDC (02268): NOTICE OF ANNUAL GENERAL MEETING | 1 | HKEx | ||
| 28.05. | WUXI XDC (02268): (1) PROPOSED RE-ELECTION AND APPOINTMENT OF DIRECTORS (2) PROPOSED GRANT OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES AND ... | 1 | HKEx | ||
| 28.05. | WUXI XDC (02268): CHANGE OF DATE OF ANNUAL GENERAL MEETING AND BOOK CLOSURE PERIOD | 1 | HKEx | ||
| 29.04. | WUXI XDC (02268): ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2024 | - | HKEx | ||
| 29.04. | WUXI XDC (02268): ANNUAL REPORT 2024 | - | HKEx | ||
| 14.04. | WUXI XDC (02268): GRANT OF RESTRICTED SHARES UNDER THE 2024 SHARE SCHEME | - | HKEx | ||
| 25.03. | Contractors WuXi Bio, WuXi XDC eye continued growth after logging solid performances in 2024 | 5 | FiercePharma | ||
| 24.03. | WuXi XDC Achieved Another Remarkable Year with Extraordinary Business Performance and Financial Results for 2024 | 165 | PR Newswire | Revenue increased by 90.8% YoY to RMB 4,052 million
Gross profit grew by 121.6% YoY to RMB 1,240 million, with its margin of 30.6%, a 4.3 percentage points increase compared to that... ► Artikel lesen | |
| 24.03. | WUXI XDC (02268): INSIDE INFORMATION 2024 ANNUAL RESULTS PRESENTATION | 1 | HKEx | ||
| 24.03. | WUXI XDC (02268): ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024 | 1 | HKEx |
1 2 Weiter >>
23 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| VALNEVA | 3,332 | +1,71 % | Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy | Original-Research: Valneva SE - von First Berlin Equity Research GmbH
28.07.2025 / 16:05 CET/CEST
Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group.
Für den... ► Artikel lesen | |
| EPIGENOMICS | 1,500 | 0,00 % | PTA-AFR: Epigenomics AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114-117 WpHG | DJ PTA-AFR: Epigenomics AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114-117 WpHG
Vorabbekanntmachung Finanzberichte gemäß ---- 114-117 WpHG
Epigenomics... ► Artikel lesen | |
| AAP IMPLANTATE | 1,910 | 0,00 % | aap Implantate: Jahresabschluss 2024 unterstreicht operativen Fortschritt | Bad Marienberg (www.anleihencheck.de) - Anbei die aktuelle Pressemitteilung der aap Implantate AG:Die aap Implantate AG ("aap" oder "Gesellschaft") gibt bekannt:- Veröffentlichung des finalen, testierten... ► Artikel lesen | |
| INFLARX | 0,780 | +3,11 % | InflaRx N.V.: InflaRx Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement | JENA, Germany, July 11, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced... ► Artikel lesen | |
| DEFENCE THERAPEUTICS | 0,390 | +4,28 % | Defence Therapeutics Inc.: Defence's Accum Technology with ADC and Radiopharmaceutical Programs Target Cancer | Montreal, Quebec--(Newsfile Corp. - July 14, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a leading biotechnology company specializing in drug... ► Artikel lesen | |
| MICROBOT MEDICAL | 2,280 | -1,21 % | Microbot Medical Inc. - 8-K, Current Report | ||
| ALDEYRA | 4,561 | +3,59 % | Hagens Berman Sobol Shapiro LLP: Aldeyra Therapeutics, Inc. (ALDX) Faces Scrutiny After Stock Drops 70% On FDA's Reproxalap Complete Response Letter - Hagens Berman | SAN FRANCISCO, April 10, 2025 /PRNewswire/ -- On April 3, 2025 investors in Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) saw the price of their shares crash over... ► Artikel lesen | |
| IMMUNIC | 0,847 | -0,24 % | EQS-News: Immunic AG: Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis | Issuer: Immunic AG
/ Key word(s): Study/Study results
Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in... ► Artikel lesen | |
| ONCO-INNOVATIONS | 1,280 | 0,00 % | Onco-Innovations Limited: Onco-Innovations Announces Private Placement | VANCOUVER, BC / ACCESS Newswire / July 29, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") announces that it intends to complete a non-brokered... ► Artikel lesen | |
| CELLECTIS | 2,475 | +3,99 % | Cellectis to Report Second Quarter 2025 Financial Results on August 4, 2025 | ||
| ESPERION | 1,254 | -1,14 % | Esperion Therapeutics soars amid vague takeover speculation | ||
| VERASTEM | 5,650 | +3,67 % | Verastem Oncology gets FDA fast track status for cancer drug | ||
| SAGE THERAPEUTICS | 7,428 | -1,46 % | Supernus Pharmaceuticals, Inc.: Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Sage Therapeutics, Inc. Tender Offer | ROCKVILLE, Md., July 28, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc., a Delaware corporation (NASDAQ: SUPN) ("Supernus", and the "Company"), today announced that the required waiting period... ► Artikel lesen | |
| UNITY BIOTECHNOLOGY | 0,082 | 0,00 % | UNITY Biotechnology, Inc. Reports First Quarter 2025 Financial Results and Business Updates | SOUTH SAN FRANCISCO, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of... ► Artikel lesen | |
| MESOBLAST | 1,340 | -4,29 % | MESOBLAST LIMITED: Becoming a substantial holder |
Das Unternehmen WUXI XDC CAYMAN INC kann der Branche Biotechnologie zugeordnet werden. Die relative Kursveränderung beträgt aktuell -2,24 % bei einem Aktienkurs von 6,550 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu WUXI XDC CAYMAN INC finden Sie auf Wallstreet Online.